Results 121 to 130 of about 55,450 (260)
Vaccines at the Heart of Hepatitis Elimination: Insights From the ESCMID Study Group for Viral Hepatitis (ESGVH). [PDF]
Săndulescu O +5 more
europepmc +1 more source
ABSTRACT Background and Aims Value‐based healthcare (VBHC) is based on evaluating clinical interventions according to their ability to improve outcomes and costs to finally enhance quality of care. As part of an initiative to introduce VBHC in inflammatory bowel disease (IBD), our project aimed to adapt the International Consortium for Health Outcomes ...
Xavier Calvet +33 more
wiley +1 more source
Closing Editorial-Special Issue on "Vaccines and Vaccination: HIV, Hepatitis Viruses and HPV". [PDF]
Moretti S, Schietroma I.
europepmc +1 more source
Intratumoral Microbiota in Tumor: Current Understandings and Future Perspectives
Intratumoral bacteria are emerging as active regulators of cancer evolution rather than bystanders. This review outlines how tumor‐resident microbes drive tumor initiation and growth by inducing genomic instability, epigenetic reprogramming, oncogenic signaling, and chronic inflammation, while promoting metastatic spread via invasion, angiogenesis ...
Jiawei Chen +6 more
wiley +1 more source
From Jenner to genomics: the unfolding future of vaccinology. [PDF]
Batool R.
europepmc +1 more source
This study revealed the active circulation of fowl adenoviruses in broiler farms in Sabah, Malaysia. FAdV‐8b and FAdV‐11 were identified in flocks with IBH lesions, accompanied by high antibody titres in unvaccinated birds. Phylogenetic analysis showed close relationships with global strains, highlighting the need for enhanced surveillance and control ...
Md. Safiul Alam Bhuiyan +5 more
wiley +1 more source
Why does hepatitis B remain underprioritized? A view through lived experience. [PDF]
Ibrahim Y +10 more
europepmc +1 more source
ABSTRACT Aim To update the Asia‐Pacific League of Associations for Rheumatology (APLAR) treatment recommendations for rheumatoid arthritis (RA) by incorporating new evidence and reassessing the validity of previous guidance: Methods A literature search for relevant publications from January 2018 to August 2023 was conducted, supplemented by earlier ...
Kunihiro Yamaoka +22 more
wiley +1 more source
Manufacturing and clinical applications of non‐CAR‐T immune effector cells
Transfusion, EarlyView.
Thane Kubik +2 more
wiley +1 more source
In ANA‐positive patients with suspected autoimmune hepatitis (AIH), liver biopsy rarely altered therapeutic management when alanine aminotransferase (ALT) was below 101 U/L and cirrhosis was absent. These findings suggest that biopsy may be safely deferred in this low‐risk group.
David Mehdi Asgher Niazi +8 more
wiley +1 more source

